Medical Aesthetics Market by Product (Botox, Dermal Filler, Chemical Peel, Liposuction, Fat Reduction, Skin Tightening, Breast Implant, Hair/Tattoo Removal, Thread Lift, Nail Treatment), End User (Medical Spa, Beauty Center) & Region - Global Forecast to 2027
Updated on : May 04, 2023
The global medical aesthetics market in terms of revenue was estimated to be worth $13.9 billion in 2022 and is poised to reach $23.4 billion by 2027, growing at a CAGR of 11.0% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The market is expanding due to factors like the rising popularity of minimally invasive and non-invasive aesthetic procedures, the rising popularity of aesthetic procedures among geriatric patients, the accessibility of technologically advanced and user-friendly products, and the rising demand for aesthetic treatments among men. This market's expansion is being held back by the clinical risks and consequences connected to medical aesthetic procedures as well as the growing accessibility and popularity of alternative beauty and cosmetic products.
To know about the assumptions considered for the study, Request for Free Sample Report
Medical Aesthetics Market Dynamics
Driver: Growing adoption of minimally invasive and noninvasive aesthetic procedures
The past decade saw a significant increase in the preference for minimally invasive and noninvasive aesthetic procedures over traditional surgical procedures. The variety of tools and techniques available to cosmetic surgeons today make minimally invasive procedures, such as eye lifts and facelifts, affordable and accessible. Furthermore, minimally invasive/nonsurgical alternatives offer advantages over traditional surgical procedures, such as less pain, reduced scarring, and quicker recovery. These procedures are also more economical than traditional surgical procedures. As per ISAPS estimations, nonsurgical cosmetic procedures have increased by 5.7% from 2019 to 2020. Some of the highlights of this data include:
- The top ten countries for aesthetic procedures in 2020 were the US, Brazil, Germany, Japan, Turkey, Mexico, Argentina, Italy, Russia, and India.
- I Nonsurgical procedures (primarily fillers and hair removal treatments) continued to increase, but by lower proportions than in previous years (5.7% in 2020, compared to 7.6% in 2019). This resulted in an overall decrease of 1.8% for all procedures.
- The most common surgical procedures worldwide during 2020 were breast augmentation making up 16% of all procedures; liposuction—15.1%; eyelid surgery—12.1%; rhinoplasty—8.4%; and abdominoplasty—7.6%.
Opportunity: Emerging markets
Emerging countries such as China, Brazil, Mexico, and India present significant opportunities for players operating in the medical aesthetics market. The demand for medical aesthetic devices in these countries is increasing owing to the rapid growth in medical tourism, the growing adult population (aged 20 and above), increasing disposable incomes, and growing awareness about aesthetic specialties. These countries are also home to a strong and qualified workforce. They have strong growth potential and the possibility of higher-than-average returns on investment. Furthermore, these countries have lenient policies for imports and exports and are underpenetrated in most aspects, which could help companies in brand development. Government subsidies and expenses or tax relaxations in these countries can also help companies grow.
Restraint: Clinical risks and complications associated with medical aesthetic procedures
Medical aesthetic procedures are associated with various side effects. Patients undergoing aesthetic treatments may face several risks and complications after or during the procedure. It also depends on patients and their ability to heal. Some complications of reconstructive cosmetic surgery are infection, excessive bleeding, and anaesthesia problems. When procedures are performed in salons, spas, or by untrained individuals, the risk of complications increases. Most of these complications are often not reported. Some of these risks are listed below:
- Hematoma or seroma: This complication is common in breast and cosmetic implants. A hematoma or seroma is a large painful blood clot near/under the surgery site.
- Nerve damage: Nerve damage results in numbness and a tingling sensation and, in extreme cases, may also result in paralysis
By product type, the facial aesthetic products segment accounted for the largest share of medical aesthetics market.
Based on product, the market is segmented into body contouring devices, cosmetic implants, facial aesthetic products, tattoo removal devices, physician-dispensed cosmeceuticals & skin lighteners, physician-dispensed eyelash products, thread lift products, skin aesthetic devices, hair removal devices, and nail treatment laser devices. The facial aesthetic products segment accounted for the largest share of the global market in 2021. The large share of this segment can be attributed to the growing patient demand for facial aesthetic treatments, increasing disposable income and spending capabilities, and the rising geriatric population across the globe.
By End User, Clinic, Hospitals, and Medical Spaces segment is expected to grow at the fastest rate of medical aesthetics market.
Based on the end user, the market is segmented into clinics, hospitals, and medical spas; beauty centers; and home care settings. Clinics, hospitals, and medical spas (or MedSpas) form the largest end-user segment in the market. Growth in this segment can be attributed to the increasing awareness about various aesthetic procedures and their benefits (resulting in the growth in the number of aesthetic procedures across the globe), growing patient preference for minimally invasive cosmetic surgeries, growth in the number of clinics and surgeons providing these treatments, and the entry of new and advanced products in the market that are resulting in enhanced patient comfort levels with aesthetic treatments.
To know about the assumptions considered for the study, download the pdf brochure
North America is expected to be the largest region of medical aesthetics market.
North America held the largest share of this market. The large share of this region is mainly due to the large volume of aesthetic procedures performed, growth in the geriatric population, rising disposable income, rising awareness, and favourable government funding for healthcare infrastructure. The rich research pipeline, the development of technologically advanced products, and FDA approvals for home-use aesthetic devices are other growth factors.
Prominent players operating in the global medical aesthetics market are AbbVie Inc. (Ireland), Galderma (Switzerland), and Merz Pharma (Germany), El.En. (Italy), Cutera (US), Venus Concept (Canada), Lutronic (US), Lumenis (Israel), Bausch Health Companies Inc. (Germany), Candela Corporation (US), InMode (Israel), and Cynosure (US) among others.
AbbVie Inc: Allergan plc, acquired by AbbVie Inc., includes a wide range of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics & dermatology, gastroenterology, women’s health, urology, and anti-infective therapeutic categories. Allergan develops, manufactures, and markets branded pharmaceuticals, devices, biologics, surgical, and regenerative medicine products. The company has a global presence with manufacturing sites in almost ten countries and operations in more than 100 countries. Allergan plc’s principal executive offices and administrative headquarters are in Dublin, Ireland.
Medical Aesthetics Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2022 |
$13.9 billion |
|
Projected Revenue by 2027 |
$23.4 billion |
|
Revenue Rate |
Poised to grow at a CAGR of 11.0% |
|
Market Driver |
Growing adoption of minimally invasive and noninvasive aesthetic procedures |
|
Market Opportunities |
Emerging markets |
This study categorizes the global medical aesthetics market to forecast revenue and analyze trends in each of the following sub-markets:
By Product
-
Facial Aesthetic Products
- Botulinum toxin
- Derma Fillers
- Microdermabrasion products
- Chemical peels
-
Cosmetic Implants
- Breast implants
- Gluteal implants
- Facial implants
-
Skin Aesthetic Devices
- Nonsurgical skin tightening devices
- Laser skin resurfacing devices
- Microneedling products
- Light therapy devices
-
Body Contouring Devices
- Nonsurgical fat reduction devices
- Cellulite reduction devices
- Liposuction devices
- Physician-Dispensed Cosmeceuticals & Skin Lighteners
-
Hair Removal Devices
- LASER hair removal devices
- IPL hair removal devices
- Tattoo Removal Devices
- Thread Lift Products
- Physician-Dispensed Eyelash Products
- Nail Treatment laser Devices
By End User
- Clinics, Hospitals, And Medical Spas
- Beauty Centers
- Home Care Settings
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Indonesia
- Rest of Asia Pacific
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Recent Developments
- In June 2022, Cynosure launched PicoSure Pro, its latest upgrade to the PicoSure platform
- In October 2020, Cynosure Announced the US and Canadian launch of FlexSure.
- In June 2020, Cynosure launched the Elite iQ Aesthetic Workstation for laser hair removal and skin revitalization in the US, Europe, and Australia.
- In February 2021, Allergan acquired by AbbVie received FDA approval for Botox to treat detrusor hyperactivity in patients five and older.
- In August 2021, Bausch Health Companies Inc. and its Solta Medical business introduced Clear + Brilliant Touch laser in the US.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global medical aesthetics market?
The global medical aesthetics market boasts a total revenue value of $23.4 billion by 2027.
What is the estimated growth rate (CAGR) of the global medical aesthetics market?
The global medical aesthetics market has an estimated compound annual growth rate (CAGR) of 11.0% and a revenue size in the region of $13.9 billion in 2022.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 30)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
FIGURE 1 MARKETS COVERED
FIGURE 2 GEOGRAPHIES COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 34)
2.1 RESEARCH DATA
FIGURE 3 MEDICAL AESTHETICS MARKET: RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARIES: GLOBAL MARKET
2.2 MARKET SIZE ESTIMATION
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 PROCEDURE-BASED MARKET ESTIMATION
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 LIMITATIONS AND RISK ASSESSMENT
3 EXECUTIVE SUMMARY (Page No. - 43)
FIGURE 9 MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 10 GLOBAL MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT: GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 46)
4.1 MEDICAL AESTHETICS MARKET OVERVIEW
FIGURE 12 GROWING ADOPTION OF MINIMALLY INVASIVE AND NONINVASIVE AESTHETIC PROCEDURES DRIVING MARKET GROWTH
4.2 NORTH AMERICA: MARKET, BY PRODUCT (USD MILLION)
FIGURE 13 FACIAL AESTHETIC PRODUCTS TO ACCOUNT FOR LARGEST SHARE
4.3 ASIA PACIFIC MARKET, BY END USER (USD MILLION)
FIGURE 14 CLINICS, HOSPITALS, MEDICAL SPAS, AND HOME CARE SETTING TO ACCOUNT FOR LARGEST SHARE
4.4 GEOGRAPHIC SNAPSHOT
FIGURE 15 ASIA PACIFIC COUNTRIES TO WITNESS HIGHEST GROWTH
5 MARKET OVERVIEW (Page No. - 50)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 MEDICAL AESTHETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing adoption of minimally invasive and noninvasive aesthetic procedures
5.2.1.2 Rising adoption of aesthetic procedures among geriatric individuals
FIGURE 17 INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2020 VS. 2025)
5.2.1.3 Availability of advanced and user-friendly products
5.2.1.4 Increasing demand for aesthetic treatments among men
5.2.2 RESTRAINTS
5.2.2.1 Clinical risks and complications associated with medical aesthetic procedures
5.2.2.2 Increasing availability and adoption of alternative products
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Development of home-use aesthetic devices
5.2.4 CHALLENGES
5.2.4.1 Social and ethical issues associated with cosmetic treatments
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 1 MEDICAL AESTHETICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 DEGREE OF COMPETITION
5.4 ECOSYSTEM COVERAGE FOR MEDICAL AESTHETICS
5.5 REGULATORY SCENARIO
5.5.1 KEY REGULATORY BODIES & GOVERNMENT AGENCIES
5.5.2 KEY REGULATORY GUIDELINES
5.5.2.1 US
5.5.2.2 Canada
5.5.2.3 UK
5.5.2.4 France
5.5.2.5 Germany
5.5.2.6 China
5.5.2.7 India
5.5.2.8 Brazil
5.5.2.9 UAE
5.6 PATENT ANALYSIS
FIGURE 18 PATENT DETAILS FOR LASER HAIR REMOVAL DEVICES (JANUARY 2012–SEPTEMBER 2022)
FIGURE 19 PATENT DETAILS FOR MEDICAL AESTHETIC DEVICES (JANUARY 2012–SEPTEMBER 2022)
FIGURE 20 PATENT DETAILS FOR BODY CONTOURING DEVICES (JANUARY 2012–SEPTEMBER 2022)
FIGURE 21 PATENT DETAILS FOR COSMETIC IMPLANTS (JANUARY 2012–SEPTEMBER 2022)
5.7 TRADE ANALYSIS
TABLE 2 IMPORT DATA FOR FACIAL AESTHETIC PRODUCTS (HS CODE 330499), BY COUNTRY, 2017-2021 (USD)
TABLE 3 EXPORT DATA FOR FACIAL AESTHETIC PRODUCTS (HS CODE 330499), BY COUNTRY, 2017-2021 (USD)
TABLE 4 IMPORT DATA FOR BREAST IMPLANTS (HS CODE 330499), BY COUNTRY, 2017-2021 (USD)
TABLE 5 EXPORT DATA FOR BREAST IMPLANTS (HS CODE ), BY COUNTRY, 2017-2021 (USD)
TABLE 6 IMPORT DATA FOR HAIR REMOVAL DEVICES (HS CODE 851030), BY COUNTRY, 2017-2021 (USD)
TABLE 7 EXPORT DATA FOR HAIR REMOVAL DEVICES (HS CODE 851030), BY COUNTRY, 2017-2021 (USD)
TABLE 8 IMPORT DATA FOR LASER DEVICES (HS CODE 901890), BY COUNTRY, 2017-2021 (USD)
TABLE 9 EXPORT DATA FOR LASER DEVICES (HS CODE 901890), BY COUNTRY, 2017-2021 (USD)
5.8 VALUE CHAIN ANALYSIS
5.8.1 RESEARCH & DEVELOPMENT
5.8.2 PROCUREMENT AND PRODUCT DEVELOPMENT
5.8.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
FIGURE 22 MEDICAL AESTHETICS: VALUE CHAIN ANALYSIS
5.9 KEY CONFERENCES & EVENTS (2022–2024)
TABLE 10 MEDICAL AESTHETICS MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS
5.10 CASE STUDIES
5.10.1 DELIVERY AND SUPPLY SOLUTIONS
TABLE 11 CASE–1: NEED TO PROVIDE MORE PLATFORMS AND EFFICIENT SUPPLY CHANNELS
5.10.2 INCREASING SALES MODELS
TABLE 12 CASE–2: TO ENHANCE SALES STRATEGIES
5.10.3 INCREASING CUSTOMER CARE AND THERAPEUTICS
TABLE 13 CASE–3: SPLITTING OPERATING BUSINESSES
6 MEDICAL AESTHETICS MARKET, BY PRODUCT (Page No. - 75)
6.1 INTRODUCTION
TABLE 14 GLOBAL MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 FACIAL AESTHETIC PRODUCTS
TABLE 15 FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 16 FACIAL AESTHETIC PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1 BOTULINUM TOXIN
6.2.1.1 Rising number of procedures to drive market growth
TABLE 17 BOTULINUM TOXIN MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.2 DERMAL FILLERS
6.2.2.1 Side effects and stringent regulations to limit use of dermal fillers
TABLE 18 DERMAL FILLERS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.3 MICRODERMABRASION PRODUCTS
6.2.3.1 Affordability of procedures to drive adoption
TABLE 19 MICRODERMABRASION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.4 CHEMICAL PEELS
6.2.4.1 Availability of a wide range of chemical peels to support their use
TABLE 20 CHEMICAL PEELS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 COSMETIC IMPLANTS
TABLE 21 COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 22 COSMETIC IMPLANTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.1 BREAST IMPLANTS
TABLE 23 BREAST IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 24 BREAST IMPLANTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.1.1 Silicone breast implants
6.3.1.1.1 Launch of new products to support market growth
TABLE 25 SILICONE BREAST IMPLANTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.1.2 Saline breast implants
6.3.1.2.1 Low cost of saline breast implants to drive market growth
TABLE 26 SALINE BREAST IMPLANTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.2 GLUTEAL IMPLANTS
6.3.2.1 Rising demand for buttock augmentation procedures to drive market growth
TABLE 27 GLUTEAL IMPLANTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.3 FACIAL IMPLANTS
6.3.3.1 Possibility of surgical scarring to restrain adoption of facial implants
TABLE 28 FACIAL IMPLANTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4 SKIN AESTHETIC DEVICES
TABLE 29 SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 30 SKIN AESTHETIC DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4.1 NONSURGICAL SKIN TIGHTENING DEVICES
6.4.1.1 Advantages over other methods to drive demand
TABLE 31 NONSURGICAL SKIN TIGHTENING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4.2 LASER SKIN RESURFACING DEVICES
6.4.2.1 Rising geriatric population to support device adoption
TABLE 32 LASER SKIN RESURFACING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4.3 MICRONEEDLING PRODUCTS
6.4.3.1 Risks associated with microneedling products to limit adoption
TABLE 33 MICRONEEDLING PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4.4 LIGHT THERAPY DEVICES
6.4.4.1 Affordability and minimal side-effects to drive market growth
TABLE 34 LIGHT THERAPY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5 BODY CONTOURING DEVICES
TABLE 35 BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 36 BODY CONTOURING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5.1 NONSURGICAL FAT REDUCTION DEVICES
6.5.1.1 Nonsurgical fat reduction devices market to witness high growth
TABLE 37 NONSURGICAL FAT REDUCTION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5.2 CELLULITE REDUCTION DEVICES
6.5.2.1 High treatment costs to limit market growth
TABLE 38 CELLULITE REDUCTION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5.3 LIPOSUCTION DEVICES
6.5.3.1 Rising number of liposuction procedures to drive device demand
TABLE 39 LIPOSUCTION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6 PHYSICIAN-DISPENSED COSMECEUTICALS & SKIN LIGHTENERS
6.6.1 PRODUCT AFFORDABILITY TO BOOST END-USER ADOPTION
TABLE 40 PHYSICIAN-DISPENSED COSMECEUTICALS & SKIN LIGHTENERS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.7 HAIR REMOVAL DEVICES
TABLE 41 HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 42 HAIR REMOVAL DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.7.1 LASER HAIR REMOVAL DEVICES
6.7.1.1 Laser hair removal devices dominates market
TABLE 43 LASER HAIR REMOVAL DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.7.2 IPL HAIR REMOVAL DEVICES
6.7.2.1 IPL hair removal procedures cover larger patches of hair and are cheaper
TABLE 44 IPL HAIR REMOVAL DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.8 TATTOO REMOVAL DEVICES
6.8.1 EMERGENCE OF PICOSECOND LASER TECHNOLOGY FOR TATTOO REMOVAL TO DRIVE MARKET GROWTH
TABLE 45 TATTOO REMOVAL DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9 THREAD LIFT PRODUCTS
6.9.1 ADOPTION OF THREAD LIFTING OVER SURGICAL PROCEDURES FOR FACIAL REJUVENATION TO DRIVE MARKET GROWTH
TABLE 46 THREAD LIFT PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.10 PHYSICIAN-DISPENSED EYELASH PRODUCTS
6.10.1 INCREASING AVAILABILITY OF EYELASH PRODUCTS TO DRIVE MARKET GROWTH
TABLE 47 PHYSICIAN-DISPENSED EYELASH PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.11 NAIL TREATMENT LASER DEVICES
6.11.1 DEVELOPMENT OF EFFICIENT AND SAFE LASER PRODUCTS TO DRIVE MARKET GROWTH
TABLE 48 NAIL TREATMENT LASER DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
7 MEDICAL AESTHETICS MARKET, BY END USER (Page No. - 105)
7.1 INTRODUCTION
TABLE 49 GLOBAL MARKET, BY END USER, 2020–2027 (USD MILLION)
7.2 CLINICS, HOSPITALS, AND MEDICAL SPAS
7.2.1 AVAILABILITY OF BETTER INFRASTRUCTURE AND RESOURCES TO SUPPORT MARKET GROWTH
TABLE 50 GLOBAL MARKET FOR CLINICS, HOSPITALS, AND MEDICAL SPAS, BY REGION, 2020–2027 (USD MILLION)
7.3 BEAUTY CENTERS
7.3.1 COST-BENEFITS ASSOCIATED WITH VISITING BEAUTY CENTERS TO SUPPORT MARKET GROWTH
TABLE 51 GLOBAL MARKET FOR BEAUTY CENTERS, BY REGION, 2020–2027 (USD MILLION)
7.4 HOME CARE SETTINGS
7.4.1 MARKET FOR HOME-USE AESTHETIC PRODUCTS EVOLVING AT A RAPID PACE
TABLE 52 GLOBAL MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)
8 MEDICAL AESTHETICS MARKET, BY REGION (Page No. - 110)
8.1 INTRODUCTION
TABLE 53 GLOBAL MARKET, BY REGION, 2020–2027 (USD MILLION)
8.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: MEDICAL AESTHETICS MARKET SNAPSHOT
TABLE 54 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 55 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 56 NORTH AMERICA: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 NORTH AMERICA: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 58 NORTH AMERICA: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 59 NORTH AMERICA: BREAST IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 60 NORTH AMERICA: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 NORTH AMERICA: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2.1 US
8.2.1.1 Growing acceptance of aesthetic surgery and high procedural volumes sustain large market share
TABLE 63 US: MEDICAL AESTHETIC PROCEDURAL DATA, 2018
TABLE 64 US: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 65 US: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 66 US: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 US: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 US: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 US: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.2.2 CANADA
8.2.2.1 Rapidly growing aging population to support market growth
TABLE 70 CANADA: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 71 CANADA: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 CANADA: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 73 CANADA: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 CANADA: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 CANADA: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3 EUROPE
TABLE 76 EUROPE: MEDICAL AESTHETICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 77 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 78 EUROPE: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 EUROPE: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 EUROPE: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 EUROPE: BREAST IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 EUROPE: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 EUROPE: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 84 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.3.1 GERMANY
8.3.1.1 Rising disposable income to drive adoption of aesthetic devices
TABLE 85 GERMANY: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 86 GERMANY: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 GERMANY: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 GERMANY: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 GERMANY: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 90 GERMANY: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 GERMANY: MEDICAL AESTHETICS PROCEDURAL DATA, 2020
8.3.2 FRANCE
8.3.2.1 Comparatively restrictive laws expected to slow market growth
TABLE 92 FRANCE: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 93 FRANCE: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 FRANCE: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 FRANCE: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 FRANCE: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 FRANCE: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.3 UK
8.3.3.1 Increasing focus on facial aesthetics to aid market growth
TABLE 98 UK: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 99 UK: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 UK: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 101 UK: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 UK: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 UK: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.4 ITALY
8.3.4.1 Rising number of plastic surgeons to drive market growth
TABLE 104 ITALY: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 105 ITALY: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 ITALY: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 ITALY: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 ITALY: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 ITALY: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.5 SPAIN
8.3.5.1 Growing demand for cosmetic procedures to drive market growth
TABLE 110 SPAIN: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 111 SPAIN: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 SPAIN: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 SPAIN: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 114 SPAIN: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 SPAIN: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.6 REST OF EUROPE
TABLE 116 ROE: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 117 ROE: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 ROE: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 ROE: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 ROE: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 121 ROE: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: MEDICAL AESTHETICS MARKET SNAPSHOT
TABLE 122 APAC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 123 APAC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 124 APAC: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 APAC: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 APAC: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 APAC: BREAST IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 APAC: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 APAC: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 APAC: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.4.1 JAPAN
8.4.1.1 Japan to dominate Asia Pacific medical aesthetics market
TABLE 131 JAPAN: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 132 JAPAN: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 JAPAN: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 JAPAN: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 135 JAPAN: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 JAPAN: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.2 CHINA
8.4.2.1 Growing availability of cosmetic surgery apps and online services to support market growth
TABLE 137 CHINA: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 138 CHINA: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 CHINA: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 CHINA: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 CHINA: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 142 CHINA: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.3 INDIA
8.4.3.1 Increasing disposable income to support market growth
TABLE 143 INDIA: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 144 INDIA: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 INDIA: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 INDIA: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 INDIA: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 INDIA: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.4 AUSTRALIA
8.4.4.1 Increasing demand for noninvasive aesthetic procedures to drive market growth
TABLE 149 AUSTRALIA: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 150 AUSTRALIA: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 AUSTRALIA: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 AUSTRALIA: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 AUSTRALIA: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 AUSTRALIA: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.5 SOUTH KOREA
8.4.5.1 Growing medical tourism to propel market growth
TABLE 155 SOUTH KOREA: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 156 SOUTH KOREA: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 157 SOUTH KOREA: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 SOUTH KOREA: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 SOUTH KOREA: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 SOUTH KOREA: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.6 THAILAND
8.4.6.1 Affordability of aesthetic procedures to boost Thailand’s medical tourism sector
TABLE 161 THAILAND: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 162 THAILAND: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 163 THAILAND: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 164 THAILAND: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 THAILAND: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 THAILAND: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.7 INDONESIA
8.4.7.1 Low cost of procedures to drive market growth
TABLE 167 INDONESIA: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 168 INDONESIA: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 INDONESIA: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 INDONESIA: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 INDONESIA: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 INDONESIA: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.8 REST OF ASIA PACIFIC
TABLE 173 ROAPAC: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 174 ROAPAC: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 ROAPAC: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 176 ROAPAC: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 177 ROAPAC: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 ROAPAC: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.5 LATIN AMERICA
TABLE 179 COST OF AESTHETIC PROCEDURES: US VS. LATAM COUNTRIES, AS OF 2018 (USD)
TABLE 180 LATAM: MEDICAL AESTHETICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 181 LATAM: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 182 LATAM: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 183 LATAM: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 LATAM: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 LATAM: BREAST IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 186 LATAM: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 187 LATAM: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 188 LATAM: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.5.1 BRAZIL
8.5.1.1 Rising medical tourism to drive market growth
TABLE 189 BRAZIL: MEDICAL AESTHETIC PROCEDURAL DATA, 2020
TABLE 190 BRAZIL: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 191 BRAZIL: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 BRAZIL: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 193 BRAZIL: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 194 BRAZIL: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 195 BRAZIL: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.5.2 MEXICO
8.5.2.1 Growing medical tourism from US to Mexico to drive market growth
TABLE 196 MEXICO: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 197 MEXICO: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 198 MEXICO: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 199 MEXICO: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 200 MEXICO: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 MEXICO: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.5.3 REST OF LATIN AMERICA
TABLE 202 ROLATAM: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 203 ROLATAM: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 204 ROLATAM: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 205 ROLATAM: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 ROLATAM: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 207 ROLATAM: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.6 MIDDLE EAST & AFRICA
8.6.1 DECLINING NUMBER OF PLASTIC SURGEONS TO LIMIT MARKET GROWTH
TABLE 208 MEA: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 209 MEA: FACIAL AESTHETIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 210 MEA: BODY CONTOURING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 MEA: COSMETIC IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 MEA: BREAST IMPLANTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 213 MEA: HAIR REMOVAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 214 MEA: SKIN AESTHETIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 215 MEA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9 COMPETITIVE LANDSCAPE (Page No. - 198)
9.1 OVERVIEW
9.2 STRATEGIES ADOPTED BY KEY PLAYERS
9.3 REVENUE SHARE ANALYSIS
9.3.1 REVENUE SHARE ANALYSIS FOR ENERGY & LIGHT-BASED MEDICAL AESTHETIC DEVICES
FIGURE 25 ENERGY & LIGHT-BASED MEDICAL AESTHETIC DEVICES: REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS (2018–2021)
9.3.2 REVENUE SHARE ANALYSIS FOR FACIAL AESTHETIC PRODUCTS
FIGURE 26 FACIAL AESTHETIC PRODUCTS MARKET: REVENUE SHARE ANALYSIS OF TOP THREE PLAYERS (2018–2021)
9.4 MARKET SHARE ANALYSIS
9.4.1 FACIAL AESTHETIC PRODUCTS MARKET SHARE ANALYSIS (2021)
FIGURE 27 FACIAL AESTHETIC PRODUCTS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 216 FACIAL AESTHETIC PRODUCTS MARKET: DEGREE OF COMPETITION
9.4.2 ENERGY & LIGHT-BASED DEVICES MARKET SHARE ANALYSIS (2021)
FIGURE 28 ENERGY & LIGHT-BASED DEVICES MARKET SHARE (2021)
TABLE 217 MEDICAL AESTHETICS: DEGREE OF COMPETITION
9.5 COMPANY EVALUATION QUADRANT (2021)
9.5.1 STARS
9.5.2 EMERGING LEADERS
9.5.3 PERVASIVE PLAYERS
9.5.4 PARTICIPANTS
FIGURE 29 MEDICAL AESTHETICS: COMPETITIVE LEADERSHIP MAPPING, 2021
9.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021)
9.6.1 PROGRESSIVE COMPANIES
9.6.2 RESPONSIVE COMPANIES
9.6.3 DYNAMIC COMPANIES
9.6.4 STARTING BLOCKS
FIGURE 30 MEDICAL AESTHETICS: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)
9.7 COMPETITIVE BENCHMARKING
9.7.1 OVERALL FOOTPRINT ANALYSIS
9.7.2 PRODUCT FOOTPRINT ANALYSIS
9.7.3 REGIONAL FOOTPRINT ANALYSIS
9.8 COMPETITIVE SCENARIO (2019–2022)
9.8.1 PRODUCT LAUNCHES & APPROVALS
9.8.2 DEALS
10 COMPANY PROFILES (Page No. - 211)
10.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MNM view)*
10.1.1 ALLERGAN
TABLE 218 ALLERGAN PLC: COMPANY OVERVIEW
FIGURE 31 ABBVIE (ALLERGAN): COMPANY SNAPSHOT (2021)
10.1.2 ALMA LASERS
TABLE 219 ALMA LASERS: COMPANY OVERVIEW
FIGURE 32 ALMA LASERS: COMPANY SNAPSHOT (2021)
10.1.3 CYNOSURE
TABLE 220 CYNOSURE: COMPANY OVERVIEW
10.1.4 BAUSCH HEALTH COMPANIES
TABLE 221 BAUSCH HEALTH COMPANIES: COMPANY OVERVIEW
FIGURE 33 BAUSCH HEALTH COMPANIES: COMPANY SNAPSHOT (2021)
10.1.5 ANIKA THERAPEUTICS
TABLE 222 ANIKA THERAPEUTICS: COMPANY OVERVIEW
FIGURE 34 ANIKA THERAPEUTICS: COMPANY SNAPSHOT (2021)
10.1.6 CUTERA
TABLE 223 CUTERA: COMPANY OVERVIEW
FIGURE 35 CUTERA: COMPANY SNAPSHOT (2021)
10.1.7 EL.EN. S.P.A.
TABLE 224 EL.EN. S.P.A.: COMPANY OVERVIEW
FIGURE 36 EL.EN.: COMPANY SNAPSHOT (2021)
10.1.8 INMODE
TABLE 225 INMODE: COMPANY OVERVIEW
FIGURE 37 INMODE: COMPANY SNAPSHOT (2021)
10.1.9 LUMENIS
TABLE 226 LUMENIS: COMPANY OVERVIEW
10.1.10 FOTONA
TABLE 227 FOTONA: COMPANY OVERVIEW
10.1.11 GALDERMA
TABLE 228 GALDERMA: COMPANY OVERVIEW
10.1.12 JOHNSON & JOHNSON
TABLE 229 JOHNSON & JOHNSON SERVICES: COMPANY OVERVIEW
FIGURE 38 JOHNSON & JOHNSON SERVICES: COMPANY SNAPSHOT (2021)
10.1.13 MERZ PHARMA
TABLE 230 MERZ PHARMA: COMPANY OVERVIEW
10.1.14 MEDYTOX
TABLE 231 MEDYTOX: COMPANY OVERVIEW
10.1.15 CANDELA CORPORATION
TABLE 232 CANDELA CORPORATION: COMPANY OVERVIEW
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
10.2 OTHER COMPANIES
10.2.1 SIENTRA
10.2.2 HUADONG MEDICINE
10.2.3 VENUS CONCEPT
10.2.4 AEROLASE CORP
10.2.5 SCITON
10.2.6 BOHUS BIOTECH AB
10.2.7 RECOSMO
10.2.8 A.R.C. LASER
10.2.9 LUTRONIC
11 APPENDIX (Page No. - 257)
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 CUSTOMIZATION OPTIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the medical aesthetics market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the medical aesthetics market. The primary sources from the demand side include medical OEMs, Analytical instrument OEMs, CDMOs and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2019, Tier 1 = >USD 1,000 million, Tier 2 = USD 500–1,000 million, and Tier 3 =
To know about the assumptions considered for the study, download the pdf brochure
Market Estimation Methodology
In this report, the global medical aesthetics market size was arrived at by using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the medical aesthetics business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.
To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involved the following steps:
- Generating a list of major global players operating in the medical aesthetic market
- Mapping annual revenues generated by major global players from the medical aesthetic segment (or nearest reported business unit/product category)
- Revenue mapping of major players to cover major share of the global market share, as of 2021
- Extrapolating the global value of the medical aesthetic industry
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the global medical aesthetics market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the medical aesthetic market was validated using both top-down and bottom-up approaches.
Objectives of the Study
- To define, describe, and forecast the Medical Aesthetics market on the basis of product, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global Medical Aesthetics market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global Medical Aesthetics market
- To analyze key growth opportunities in the global Medical Aesthetics market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, Thailand, Indonesia and the RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), and the Middle East & Africa
- To profile the key players in the global Medical Aesthetics market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global Medical Aesthetics market, such as product launches; agreements; expansions; and mergers & acquisitions
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global medical aesthetics market report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top five companies
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe medical aesthetic market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
- Further breakdown of the Rest of Asia Pacific medical aesthetic market into Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
- Further breakdown of the Latin American medical aesthetic market into Colombia, Chile, Argentina, and Peru, among other
Top 10 companies in aesthetic medicine market
The aesthetic medicine market is a rapidly growing industry with a wide range of companies providing various products and services. Here are the top 10 companies in the aesthetic medicine market, ranked by revenue:
- Allergan Aesthetics
- Galderma
- Merz Pharma
- Sinclair Pharma
- Syneron Candela
- Cynosure
- Lumenis
- Cutera
- Alma Lasers
- Venus Concept
Which newer applications of Aesthetic Medicine is Allergan Aesthetics targeting in future?
Allergan Aesthetics, a subsidiary of AbbVie, is one of the leading companies in the Aesthetic Medicine market, with a broad portfolio of products and treatments. While I do not have access to their latest product development plans or marketing strategies, here are some of the newer applications and products that Allergan Aesthetics has recently targeted or launched in the Aesthetic Medicine market
Body contouring: Allergan Aesthetics has recently launched a non-invasive body contouring treatment called CoolSculpting Elite, which uses cryolipolysis to target and eliminate stubborn fat cells.
Male aesthetics: Allergan Aesthetics has recognized the growing market for male aesthetics and has launched products specifically targeting men, including the injectable treatment BOTOX Cosmetic for Men and the hair restoration treatment Kybella.
Skin rejuvenation: Allergan Aesthetics offers a range of skin rejuvenation products and treatments, including the dermal fillers JUVÉDERM VOLUMA XC and JUVÉDERM VOLBELLA XC, which can help smooth and plump the skin.
Digital marketing: Allergan Aesthetics has embraced digital marketing and has launched a number of online resources for patients, including the Alle loyalty program, which rewards patients for their loyalty and engagement with Allergan Aesthetics products.
Patient safety: Allergan Aesthetics has also prioritized patient safety, investing in research and development to ensure the safety and efficacy of their products and treatments.
It's worth noting that the Aesthetic Medicine market is constantly evolving, with new treatments and applications being developed all the time. Allergan Aesthetics and other companies in the industry will need to stay on top of these trends and continue to innovate in order to stay competitive and meet the evolving needs of patients.
How Galderma is trying to grow its Aesthetic Medicine business in medical spa and beauty center sector?
Galderma is one of the leading companies in the Aesthetic Medicine market, with a strong portfolio of products and treatments. The company has a range of initiatives aimed at growing its Aesthetic Medicine business in the medical spa and beauty center sector. Here are a few examples
Product portfolio: Galderma has a wide range of products specifically designed for use in medical spas and beauty centers, including the dermal fillers Restylane and Sculptra, as well as the neuromodulator Dysport. These products are marketed as safe, effective, and long-lasting options for patients seeking cosmetic treatments.
Partnerships: Galderma has established partnerships with a number of medical spas and beauty centers, providing them with training and support in the use of Galderma products. These partnerships help to ensure that Galderma products are used safely and effectively, while also promoting the company's brand and expanding its reach.
Education and training: In addition to partnerships, Galderma also provides education and training programs for medical spa and beauty center staff. These programs help to ensure that staff are knowledgeable and skilled in the use of Galderma products, further enhancing patient safety and satisfaction.
Marketing and advertising: Galderma has also invested in marketing and advertising campaigns targeted at medical spa and beauty center customers. These campaigns aim to raise awareness of Galderma products and services, while also building the company's brand and reputation in the market.
Overall, Galderma is taking a multi-pronged approach to growing its Aesthetic Medicine business in the medical spa and beauty center sector. By offering a strong product portfolio, partnering with key players in the industry, providing education and training, and investing in marketing and advertising, the company is well-positioned to capture a growing share of this market.
How Merz Pharma is reducing cost of Aesthetic Medicine; Analysis by raw materials and technology?
Merz Pharma is one of the leading companies in the Aesthetic Medicine market, and like many other companies in the industry, it is always looking for ways to reduce costs in order to stay competitive. Here are a few ways that Merz Pharma has worked to reduce costs in its Aesthetic Medicine business
Use of alternative materials: Merz Pharma has invested in the development of alternative raw materials that are less expensive than traditional materials. For example, the company has developed a dermal filler called Belotero Balance that is made from a material called hyaluronic acid, which is less expensive than some other materials used in fillers.
Manufacturing process optimization: Merz Pharma has optimized its manufacturing processes to reduce costs. This includes streamlining the production process, reducing waste, and implementing more efficient quality control procedures.
Technology improvements: Merz Pharma has also invested in technology to improve its production processes and reduce costs. For example, the company has developed a technology called the Electronic Quality Management System (eQMS), which uses electronic signatures and workflows to simplify and speed up quality control processes.
Supply chain optimization: Merz Pharma has also worked to optimize its supply chain, reducing transportation and logistics costs by sourcing raw materials locally when possible and working with logistics partners to improve efficiency.
Overall, Merz Pharma's approach to reducing costs in its Aesthetic Medicine business involves a combination of alternative materials, manufacturing process optimization, technology improvements, and supply chain optimization. By continuing to invest in these areas, the company is well-positioned to reduce costs and maintain its competitive edge in the market.
Key challenges for growing Aesthetic Medicine business in cosmetic industry in the future
The Aesthetic Medicine industry is a rapidly growing and evolving field, but there are several key challenges that companies may face as they look to grow their businesses in the cosmetic industry in the future. Here are a few of the main challenges
Competition: As the Aesthetic Medicine market continues to grow, competition among companies is likely to increase. Companies will need to continue to innovate and differentiate themselves in order to stand out in the crowded market.
Cost: Aesthetic Medicine treatments can be expensive, and as the market becomes more competitive, companies will need to find ways to reduce costs in order to remain competitive. This could include optimizing manufacturing processes, sourcing alternative raw materials, and improving supply chain efficiency.
Regulatory environment: The Aesthetic Medicine industry is subject to a complex regulatory environment, with regulations and guidelines varying from country to country. Companies will need to stay up-to-date with the latest regulations and ensure that they are in compliance in order to avoid penalties or legal issues.
Public perception: While Aesthetic Medicine treatments are becoming increasingly popular, there is still some stigma attached to the industry. Companies will need to work to educate the public on the safety and benefits of these treatments in order to overcome this stigma and attract more customers.
Technological advancements: The Aesthetic Medicine industry is constantly evolving, with new technologies and treatments emerging all the time. Companies will need to stay up-to-date with the latest developments in order to remain competitive and continue to meet the evolving needs and preferences of their customers.
Overall, the Aesthetic Medicine industry faces several key challenges as it looks to grow its business in the cosmetic industry in the future. By addressing these challenges proactively and with a focus on innovation and differentiation, companies can position themselves for continued success in this exciting and rapidly growing field.
Impact of recession on Aesthetic Medicine market
The impact of a recession on the Aesthetic Medicine market can be complex and multifaceted. Here are some of the potential impacts of a recession on the Aesthetic Medicine market
Decline in disposable income: During a recession, people tend to have less disposable income, which can lead to a decrease in demand for elective procedures like those offered in the Aesthetic Medicine market.
Increase in price sensitivity: When disposable income is reduced, patients may become more price-sensitive, seeking out less expensive treatment options or delaying procedures until they can better afford them.
Shift in priorities: During a recession, patients may prioritize basic needs over elective procedures, leading to a decline in demand for Aesthetic Medicine services.
Reduced availability of financing: Financing options for Aesthetic Medicine procedures, such as loans or payment plans, may become more difficult to obtain during a recession, further reducing demand.
Increased competition: In response to reduced demand, Aesthetic Medicine providers may lower prices or offer discounts, leading to increased competition in the market.
Delayed adoption of new technologies: During a recession, providers may be more cautious about investing in new technologies or procedures, leading to a slowdown in innovation in the Aesthetic Medicine market.
Overall, the impact of a recession on the Aesthetic Medicine market is dependent on a range of factors, including the severity and duration of the recession, as well as the availability of financing options and shifts in patient priorities. While a recession may lead to a short-term decline in demand for Aesthetic Medicine services, the market has shown resilience in the past and is expected to continue to see long-term growth over time.
Generating Response ...
Growth opportunities and latent adjacency in Medical Aesthetics Market